Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology
The DOI matches its Crossref record.
Abstract
Despite over 50 yr of experience with steroid replacement therapy, the management of congenital adrenal hyperplasia (CAH) remains difficult, and clinical practice varies substantially throughout the world. To consider the evidence for best practice, to formulate management guidelines, and to consider innovative therapies, The Lawson Wilkins Pediatric Endocrine Society (LWPES) and The European Society for Pediatric Endocrinology (ESPE) convened a meeting in Gloucester, MA, March 14–17, 2002. The 40 participating physicians, psychologists, scientists, and surgeons from 12 countries on 4 continents agreed with the following consensus statement; this statement is concerned exclusively with CAH caused by 21-hydroxylase deficiency and does not address the other, rarer forms of CAH. The newborn female with CAH and ambiguous external genitalia requires urgent expert medical attention. The ambiguity is highly distressing to the family; therefore, immediate comprehensive evaluation is needed by referral to, or a visit by, a pediatric endocrinologist. An important goal is to ensure that the parents develop a positive relationship with their child. A well-organized multidisciplinary team (including specialists in pediatric endocrinology, psychosocial services, pediatric surgery/urology, and genetics) is essential for the diagnosis and management of the infant with ambiguous genitalia. It is important that the coordinator of the team has experience in the long-term care of the patient with CAH and provides a consistent message to the parents. Every newborn with ambiguous genitalia, a suspected diagnosis of CAH, or an abnormal result in a newborn screen for 17-hydroxyprogesterone (17OHP) should be evaluated by a pediatric endocrinologist. The evaluation of an infant with ambiguous genitalia includes a complete history, a physical examination, a reliable ultrasound investigation of the internal genitalia and adrenals, karyotype or fluorescence in situ hybridization for sex chromosome material, and a rapid, reliable plasma or serum measurement of 17OHP. Premature newborns may need serial measurements of 17OHP to differentiate false positive results from affected infants with CAH. Neonatal mass screening for 21-hydroxylase deficiency identifies both male and female affected infants, prevents incorrect sex assignment, and decreases mortality and morbidity (1–4). Therefore, newborn screening for CAH is beneficial and is recommended. Newborn screening is sufficiently specific and sensitive to detect almost all infants with classical CAH and some infants with nonclassical CAH (NCCAH). Sampling of blood spots should be performed, ideally between 48 and 72 h of age, and sent to the screening laboratory without delay. At present, direct binding assays for blood-spot 17OHP are the only practical method for screening. Each screening laboratory needs to establish validated cut-off levels related to gestational age and birth-weight, because 17OHP levels decline with increasing gestational age. Only laboratories with excellent internal and external quality control, demonstrated accuracy, and a rapid turn-around time on a large number of samples should be used. The laboratory should report immediately any abnormal result to the physician responsible for the patient. A reliable CAH screening program requires both clinical evaluation and laboratory investigation for diagnostic confirmation. A positive screening result needs to be confirmed either by a validated 17OHP measurement of a second serum/plasma sample, a urine sample for a steroid profile, or analysis of the CYP21 gene. Newborn screening, using 17OHP, may detect other forms of CAH. In uncertain cases, additional specific tests are required. Measurements of androstenedione, aldosterone, cortisol, and testosterone by direct immunoassays are of limited value for diagnosis in the newborn. Molecular genetic analysis is not essential for the diagnosis but may be helpful to confirm the basis of the defect, to aid in genetic counseling, and to establish the diagnosis in uncertain cases. Ten mutations account for 90–95% of the affected alleles, but molecular genetic analysis is complicated by multiple copies of the genes and the possibility of multiple mutations on one allele (5, 6). The clinical features may not correlate with the genetic mutation in a small percentage of cases. Parental DNA samples are essential to segregate alleles. Salt wasters may not be apparent in the first days, or even weeks, after birth by electrolyte measurements. Salt wasters may be differentiated from simple virilizers by serial serum/plasma and/or urine electrolytes, plasma renin activity (PRA) or direct renin, and the results of CYP21 molecular analysis. Prenatal treatment has been advocated for fetuses at risk for classic CAH but is not appropriate for nonclassic CAH. The appropriateness, ethics, and outcomes of the prenatal treatment of CAH with dexamethasone remain controversial (7, 8). However, based on
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Life-long treatment with glucocorticoids will restore any cortisol deficiency and suppress ACTH secretion and subsequent androgen production (27).”
From ACTH Antagonists (2016) · cites this paper as [27]
In the citing paper
“21-Hydroxylase deficiency, caused by mutations in P450c21, is the most common form of CAH and one of the most common inborn errors of metabolism.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [408]
In the citing paper
“After appropriate fluid resuscitation, the mineralocorticoids and glucocorticoids can be replaced orally, and the ambiguous genitalia can be corrected with a series of plastic surgical procedures, but the management is complicated and difficult (408, 410).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [408]
Citations
Cites
Still being checked.
Cited by
Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., et al. (2012) · International Journal of Transgenderism · doi:10.1080/15532739.2011.700873 · Cited by 3,143
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Adrenal insufficiency: still a cause of morbidity and death in childhood
Shulman, D. I., Palmert, M. R., Kemp, S. F., & for the Lawson Wilkins Drug and Therapeutics Committee (2007) · PEDIATRICS · doi:10.1542/peds.2006-1612 · Cited by 282
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Hirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., Wedell, A., & Lajic, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1340 · Cited by 228
Management of disorders of sex development
Hiort, O., Birnbaum, W., Marshall, L., Wünsch, L., Werner, R., Schröder, T., Döhnert, U., & Holterhus, P.-M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.108 · Cited by 181
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0062 · Cited by 174
Nordenström, A., Frisén, L., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2639 · Cited by 161
Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: a pilot study
Crouch, N. S., Minto, C. L., Laio, L. ‐., Woodhouse, C. R. J., & Creighton, S. M. (2004) · BJU International · doi:10.1111/j.1464-410x.2004.04572.x · Cited by 162
Fractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151
Disorders of sex development (DSDs), their presentation and management in different cultures
Warne, G. L., & Raza, J. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9084-2 · Cited by 149
ATTITUDES OF ADULT 46,XY INTERSEX PERSONS TO CLINICAL MANAGEMENT POLICIES
MEYER-BAHLBURG, H. F. L., MIGEON, C. J., BERKOVITZ, G. D., GEARHART, J. P., DOLEZAL, C., & WISNIEWSKI, A. B. (2004) · Journal of Urology · doi:10.1097/01.ju.0000117761.94734.b7 · Cited by 139
Bonfig, W., Dalla Pozza, S. B., Schmidt, H., Pagel, P., Knorr, D., & Schwarz, H. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0942 · Cited by 136
Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Management of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70138-4 · Cited by 134
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Verma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03636.x · Cited by 126
Approach to the patient: the adult with congenital adrenal hyperplasia
Auchus, R. J., & Arlt, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1440 · Cited by 121
Hyett, J. A., Gardener, G., Stojilkovic-Mikic, T., Finning, K. M., Martin, P. G., Rodeck, C. H., & Chitty, L. S. (2005) · Prenatal Diagnosis · doi:10.1002/pd.1284 · Cited by 110
Non-invasive fetal sex determination: Impact on clinical practice
Finning, K. M., & Chitty, L. S. (2008) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2007.12.007 · Cited by 115
Mercè Fernández‐Balsells, M., Muthusamy, K., Smushkin, G., Lampropulos, J. F., Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., Agrwal, N., Gallegos‐Orozco, J. F., Lane, M. A., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03826.x · Cited by 101
Merza, Z., Rostami‐Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell‐Price, J., Tucker, G. T., & Ross, R. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02544.x · Cited by 98
Tardy-Guidollet, V., Menassa, R., Costa, J.-M., David, M., Bouvattier-Morel, C., Baumann, C., Houang, M., Lorenzini, F., Philip, N., Odent, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2895 · Cited by 96
Jenkins-Jones, S., Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., & Ross, R. J. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0895 · Cited by 85
Sciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82
Impact of the consensus statement and the new DSD classification system
Pasterski, V., Prentice, P. M., & Hughes, I. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.004 · Cited by 97
Hirvikoski, T., Nordenström, A., Wedell, A., Ritzén, M., & Lajic, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1222 · Cited by 80
Lee, P. A., Houk, C. P., & Husmann, D. A. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.03.116 · Cited by 77
Berenbaum, S. (2006) · Annual Review of Sex Research · doi:10.1080/10532528.2006.10559835 · Cited by 53
Monitoring of Therapy in Congenital Adrenal Hyperplasia
Dauber, A., Kellogg, M., & Majzoub, J. A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146035 · Cited by 72
Braga, L. H. P., Lorenzo, A. J., Tatsuo, E. S., Silva, I. N., & Pippi Salle, J. L. (2006) · Journal of Urology · doi:10.1016/j.juro.2006.07.063 · Cited by 70
Wang, L. C., & Poppas, D. P. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.021 · Cited by 78
Auchus, R., Witchel, S., Leight, K., Aisenberg, J., Azziz, R., Bachega, T., Baker, L., Baratz, A., Baskin, L., Berenbaum, S., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-275213 · Cited by 66
Practice changes in childhood surgery for ambiguous genitalia?
Michala, L., Liao, L., Wood, D. N., Conway, G. S., & Creighton, S. (2014) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2014.01.030 · Cited by 74
Changing attitudes to sex assignment in intersex
Creighton, S., & Liao, L. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04694.x · Cited by 79
Management considerations for the adult with congenital adrenal hyperplasia
Auchus, R. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.039 · Cited by 65
Central Precocious Puberty: Current Treatment Options
Antoniazzi, F., & Zamboni, G. (2004) · Pediatric Drugs · doi:10.2165/00148581-200406040-00002 · Cited by 83
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Nonclassic adrenal hyperplasia
Speiser, P. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9097-x · Cited by 68
Madathilethu, J., Roberts, M., Peak, M., Blair, J., Prescott, R., & Ford, J. L. (2018) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2017-000198 · Cited by 71
Childhood surgery for ambiguous genitalia: glimpses of practice changes or more of the same?
Creighton, S., Michala, L., Mushtaq, I., & Yaron, M. (2013) · Psychology and Sexuality · doi:10.1080/19419899.2013.831214 · Cited by 79
Gatelais, F., Berthelot, J., Beringue, F., Descamps, P., Bonneau, D., Limal, J.-M., & Coutant, R. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000142733.50918.6e · Cited by 60
Thyen, U., Lux, A., Jürgensen, M., Hiort, O., & Köhler, B. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2917-7 · Cited by 65
Non‐invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound
Avent, N. D., & Chitty, L. S. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1493 · Cited by 67
Pediatric Adrenal Insufficiency: Diagnosis, Management, and New Therapies
Bowden, S. A., & Henry, R. (2018) · International Journal of Pediatrics · doi:10.1155/2018/1739831 · Cited by 60
Use of aromatase inhibitors to increase final height
Dunkel, L. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.031 · Cited by 68
The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS) – an extended critical analysis
Geisthövel, F., & Rabe, T. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60902-9 · Cited by 68
Bachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Ontogeny of adrenal steroid biosynthesis: why girls will be girls
White, P. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28296 · Cited by 53
`But We Have to Do Something': Surgical `Correction' of Atypical Genitalia
Roen, K. (2008) · Body & Society · doi:10.1177/1357034x07087530 · Cited by 66
Prenatal management of disorders of Sex development
Chitty, L. S., Chatelain, P., Wolffenbuttel, K. P., & Aigrain, Y. Y. (2012) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2012.10.012 · Cited by 58
Keen‐Kim, D., Redman, J. B., Alanes, R. U., Eachus, M. M., Wilson, R. C., New, M. I., Nakamoto, J. M., & Fenwick, R. G. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60550-8 · Cited by 54
Total and Partial Urogenital Mobilization: Focus on Urinary Continence
Palmer, B. W., Trojan, B., Griffin, K., Reiner, W., Wisniewski, A., Frimberger, D., & Kropp, B. P. (2012) · Journal of Urology · doi:10.1016/j.juro.2011.12.012 · Cited by 50
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Screening for neonatal endocrinopathies: rationale, methods and results
Vliet, G. V., & Czernichow, P. (2003) · Seminars in Neonatology · doi:10.1016/s1084-2756(03)00115-5 · Cited by 55
Increased salt appetite in patients with congenital adrenal hyperplasia 21-hydroxylase deficiency
Kochli, A., Tenenbaum-Rakover, Y., & Leshem, M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00713.2004 · Cited by 50
Hirvikoski, T., Lindholm, T., Lajic, S., & Nordenström, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02260.x · Cited by 49
Assignment of the sex of rearing in the neonate with a disorder of sex development
Mieszczak, J., Houk, C. P., & Lee, P. A. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32832c6d2c · Cited by 53
Long-Term Outcome of Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
Mnif, M. F., Kamoun, M., Mnif, F., Charfi, N., Kallel, N., Naceur, B. B., Rekik, N. M., Abid, M., Mnif, Z., Sfar, M. H., et al. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31824369e4 · Cited by 54
Bougneres, P. F., Bouvattier, C. M., Cartigny, M., & Michala, L. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-016-0040-8 · Cited by 57
Caldato, M. C. F., Fernandes, V. T., & Kater, C. E. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500017 · Cited by 48
Brunetti, G., D’Amato, G., Chiarito, M., Tullo, A., Colaianni, G., Colucci, S. C., Grano, M., & Faienza, M. F. (2018) · World Journal of Pediatrics · doi:10.1007/s12519-018-0198-7 · Cited by 60
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
Ng, S. M., Stępień, K. M., & Krishan, A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012517.pub2 · Cited by 58
Congenital adrenal hyperplasia and lower urinary tract symptoms
Davies, M. C., Crouch, N. S., Woodhouse, C. R. J., & Creighton, S. M. (2005) · BJU International · doi:10.1111/j.1464-410x.2005.05516.x · Cited by 48
Huynh, T., McGown, I. N., Cowley, D. M., Nyunt, O., Leong, G. M., Harris, M. A., & Cotterill, A. M. (2009) · PubMed Central · Cited by 60
Nimkarn, S., & New, M. I. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0481 · Cited by 55
Anatomical Studies of the Female Genitalia: Surgical Reconstructive Implications
Baskin, L. S. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.4.581 · Cited by 48
Clark, A. J., Forfar, R., Hussain, M., Jerman, J., McIver, E., Taylor, D., & Chan, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00101 · Cited by 49
Brunetti, G., Faienza, M. F., Piacente, L., Ventura, A., Oranger, A., Carbone, C., Benedetto, A. D., Colaianni, G., Gigante, M., Mori, G., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00535.2012 · Cited by 46
Faienza, M. F., Brunetti, G., Colucci, S. C., Piacente, L., Ciccarelli, M., Giordani, L., Vecchio, G., D’Amore, M., Albanese, L., Cavallo, L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2446 · Cited by 50
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/494173 · Cited by 45
Dreger, A., Feder, E. K., & Tamar-Mattis, A. (2012) · Journal of Bioethical Inquiry · doi:10.1007/s11673-012-9384-9 · Cited by 43
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Aurón, M., & Raissouni, N. (2015) · Pediatrics in Review · doi:10.1542/pir.36-3-92 · Cited by 61
Krone, N., Grischuk, Y., Müller, M., Volk, R. E., Grötzinger, J., Holterhus, P.-M., Sippell, W. G., & Riepe, F. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0209 · Cited by 43
Diagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Ezquieta, B., Beneyto, M., Muñoz-Pacheco, R., Barrio, R., Oyarzabal, M., Lechuga, J. L., Luzuriaga, C., Hermoso, F., Quinteiro, S., & Martinez, S. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1584 · Cited by 40
Disorders of Sexual Differentiation
T'Sjoen, G. G. (2006) · Springer eBooks · doi:10.1007/3-540-33713-x_8 · Cited by 37
Auer, M. K., Fuß, J., Stalla, G. K., & Athanasoulia, A. P. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.047 · Cited by 41
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 44
Nabhan, Z. M., & Lee, P. (2007) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/gco.0b013e3282eeb13d · Cited by 272
Observation of hypertension in children with 21-hydroxylase deficiency: A preliminary report
Nebesio, T. D., & Eugster, E. A. (2006) · Endocrine · doi:10.1007/s12020-006-0005-4 · Cited by 39
Kopacek, C., de Castro, S. M., Prado, M. J., da Silva, C. M. D., Beltrão, L. A., & Spritzer, P. M. (2017) · BMC Pediatrics · doi:10.1186/s12887-016-0772-x · Cited by 36
Urinary continence outcomes following vaginoplasty in patients with congenital adrenal hyperplasia
Stites, J., Bernabé, K. J., Galan, D., Felsen, D., & Poppas, D. P. (2017) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2016.10.012 · Cited by 35
Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia
Hicks, R. A., Yee, J. K., Mao, C. S., Graham, S., Kharrazi, M., Lorey, F., & Lee, W. P. (2014) · Metabolomics · doi:10.1007/s11306-013-0558-1 · Cited by 35
Surgical management of the intersex patient: an overview in 2003
Nihoul‐Feketé, C. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2003.12.039 · Cited by 35
Schaeffer, T. L., Tryggestad, J. B., Mallappa, A., Hanna, A., Krishnan, S., Chernausek, S. D., Chalmers, L. J., Reiner, W. G., Kropp, B. P., & Wisniewski, A. B. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/692439 · Cited by 45
Body Image and Sexuality in Indonesian Adults with a Disorder of Sex Development (DSD)
Ediati, A., Juniarto, A. Z., Birnie, E., Drop, S. L. S., Faradz, S. M. H., & Dessens, A. B. (2015) · The Journal of Sex Research · doi:10.1080/00224499.2013.816260 · Cited by 34
Treatment guidelines for children with disorders of sex development
Meyer-Bahlburg, H. F. L. (2008) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2008.06.002 · Cited by 33
Sturm, R. M., Durbin-Johnson, B., & Kurzrock, E. A. (2015) · Journal of Urology · doi:10.1016/j.juro.2014.11.008 · Cited by 33
Kalfa, N., Liu, B., Cao, M., Vilella, M., Hsieh, M., & Baskin, L. S. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.03.089 · Cited by 32
Cognitive function in children with classic congenital adrenal hyperplasia
Hamed, S. A., Metwalley, K. A., & Farghaly, H. S. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3226-7 · Cited by 33
Adrenal Disorders in Pregnancy
Abdelmannan, D. K., & Aron, D. C. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.09.001 · Cited by 35
Congenital adrenal hyperplasia in adults
Auchus, R. J. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833961d7 · Cited by 30
Metadata
- Authors
- Joint LWPES/ESPE CAH Working Group
- Corresponding author
- Joint LWPES/ESPE CAH Working Group
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-09
- Volume
- 87
- Issue
- 9
- Pages
- 4048-4053
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W4234360283
- Cited by
- 332
- References
- 0
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 10 · 2023: 3 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 15 · 2018: 17 · 2017: 9 · 2016: 13 · 2015: 12 · 2014: 13 · 2013: 22 · 2012: 17
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- European Society for Paediatric Endocrinology
- European Society of Endocrinology
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, ambiguous genitalia, newborn screening, 17-hydroxyprogesterone, steroid replacement therapy, cortisol, fludrocortisone, glucocorticoid therapy, multidisciplinary care, gender assignment, psychosocial support
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adrenalectomy, Female, Glucocorticoids, Humans, Pregnancy, Prenatal Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.